Eden Research plc has received regulatory approval from the United States Environmental Protection Agency (EPA) for its biopesticides Mevalone and Cedroz.
Eden Research plc is a British company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection. It has a number of products to target diseases such as powdery mildew and downy mildew.
Eden now received regulatory approval from the EPA, for all five petitions submitted, covering the company’s three active ingredients (eugenol, geraniol and thymol) and two formulated products (Mevalone and Cedroz).
Eden states the EPA approval will open significant revenue opportunities, with total market potential of approximately €94m for Mevalone and €189m for Cedroz. In addition, the company expects that ultimately the registration of Eden’s developmental insecticide will follow a shortened timeline as it is based upon the now-approved active ingredients.
Eden will pursue registration of this new product in due course based upon the outcome of field trials. The total market potential for the insecticide is €237m.
Coastal and southern states such as California and Florida will be the initial focus for the use of Eden’s products given the prevalence of high value horticultural crops. Marketing of the products will commence as soon as possible, subject to state level regulatory approval in these regions, which is expected in the coming months. Assuming timely state-level authorisations, meaningful sales are expected to commence in 2023.
Worldwide, the use of conventional products that guard crops against weed pressure, disease and pests is increasing falling out of favour. Many products are being phased out in the EU and elsewhere. These are the Top four natural crop protection products.